Future Prospects of Global Laboratory Proficiency Testing Market

Image
Laboratory Proficiency Testing Market  The global Laboratory Proficiency Testing Market is estimated to be valued at US$ 1.29 billion in 2023 and is expected to exhibit a CAGR of 7.3% over the forecast period 2023 - 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Laboratory proficiency testing involves evaluating the performance of laboratories for a given scope of testing through inter-laboratory comparisons. It helps assess the quality and competence of laboratories by determining reproducibility and accuracy of test results. Proficiency testing products are used by laboratories to determine method validity and accuracy, and improve testing processes. Market Key Trends: One of the major trends in the laboratory proficiency testing market is the growing number of accredited medical laboratories. Accreditation assures compliance with ISO 15189 and ISO/IEC 17025 standards, which require participation in proficiency testing programs. Acc...

Global Recombinant Vaccines Market Insights, Size, Share, Opportunity Analysis, and Industry Forecast till 2025

 

Recombinant Vaccines Market
Recombinant Vaccines Market

Vaccines were first developed by chance, depending on pathogen attenuation or inactivation. By bringing vaccines to market, recent developments in gene splicing, genomics, and recombinant DNA technologies have changed vaccine development. To assure safety and efficacy, the vaccine is genetically modified and made in a laboratory, removing the risk of infectious viral antigens. The recombinant vaccine was created using recombinant deoxyribonucleic acid technology. Recombinant vaccines use a variety of expression methods, including yeast, bacteria, and mammalian cells, to precisely manufacture their antigenic proteins.

The global Recombinant Vaccine market was valued at US$ 830.2 million in 2016 and is expected to witness a robust CAGR of 6.0% during the forecast period (2017 – 2025).

According to the World Health Organization (WHO), roughly 18 million people died because treatment for their sickness was unavailable. According to a 2017 World Health Organization report, immunisation can prevent 2 million to 3 million fatalities in the United States each year, with 1.5 million deaths easily avoided. Around 19.5 million infants were not given a basic immunisation. Companies are working on the creation of new vaccinations for various diseases such as the Zika virus, cancer, and others due to ongoing technological advancements.

Recombinant vaccines are developed more quickly than other traditional vaccine development methods, which has increased their market prominence. Furthermore, such vaccinations avoid the need to handle live viruses, ensuring development safety. The industry has been bolstered by increased spending in research and development for recombinant vaccines against various viral and bacterial infections.

Comments

Popular posts from this blog

Future Prospects of Global Laboratory Proficiency Testing Market

Survival Suits Market Size, Share, Outlook, and Opportunity Analysis, 2023-2030

Global Ophthalmoscopes Market Overview and Impact of Coronavirus (Covid-19) Pandemic